lung disease
Breakthrough in EGFR-Mutated NSCLC: Rybrevant Plus Lazcluze Extends Overall Survival
The bispecific antibody Rybrevant plus Lazcluze significantly extended overall survival in patients with locally ...
MARCH 17, 2025
Rigel Pharmaceuticals Acquires U.S. Rights to Gavreto
Rigel Pharmaceuticals announced that it has entered into a definitive agreement to acquire the U.S. rights to ...
MAY 20, 2024
New Rx Option Breathes Some Life Into MAC Lung Disease
For the treatment of refractory MAC lung disease, Arikayce, first approved by the FDA in 2018, remains effective in ...
MAY 19, 2023
More Questions Than Answers as Vaping-Related Lung Cases, Deaths Increase
Any health care provider who sees a patient with symptoms after vaping should report the case, the CDC said.
SEPTEMBER 19, 2019
Load more